Research and Development

The Scottish Medicines Consortium (SMC) has announced that empagliflozin (Jardiance®) has been accepted for use by NHS Scotland, for the …

COVAX has purchased more than 210 million doses of their vaccine for delivery to low income countries. This supply agreement …

An entire town in Brazil has been enrolled by Pfizer to study the transmission of the coronavirus within a vaccinated …

The WHO has given the go-ahead for the mass roll out of a malaria vaccine for children, in a historic …

The Janssen Pharmaceutical Companies of J&J have announced that STELARA® (ustekinumab) has a high safety profile in older patients across …

UroGen Pharma Ltd has published results from the Phase IIb OPTIMA II trial, a single-arm trial studying UGN-102 (mitomycin) as …

The EMA have authorised the third dose of the Moderna COVID-19 vaccine (Spikevax), to be administered on immunocompromised individuals aged …

Merck announced on Wednesday a supply and purchase agreement that will provide Singapore with access to its experimental oral COVID-19 …

Bayer AG has won its first court case over claims its Roundup weed killer causes cancer after a California jury …

Researchers from the University of California have created an electrical implant that sits in the skull, wired to the brain, …

NICE has announced on Tuesday that for the first time in 20 years, a new treatment will be made available …

AstraZeneca and Daiichi Sankyo have today announced that the FDA has granted Enhertu (fam-trastuzumab deruxtecan-nxki) breakthrough therapy designation (BTD) for …

Clinical stage biopharmaceutical company, Avacta Group plc, has announced that a preclinical development milestone has been achieved in the partnership …

New data show that Novartis Cosentyx (secukinumab) 300-mg single dose autoinjector resulted in high efficacy vs placebo. Cosentyx is a …

Biopharmaceutical company Acacia Pharma Group plc (Acacia Pharma) has announced that its Marketing Authorisation Application (MAA) for BARHEMSYS® (amisulpride injection) …